FDA Issues Class I Recall for Draeger VentStar Resus Neo Hoses Due to Risk of Ventilation Failure

The U.S. Food and Drug Administration (FDA) has classified the recall of Draeger VentStar Resus Neo hoses as Class I, the most serious type of recall. The recall is due to reports of cracks in the hose, which could lead to restricted ventilation, delayed therapy, desaturation, hypoxia, or patient death if used. Draeger has reported no serious injuries or deaths associated with this issue as of September 3, 2026.

Context

Draeger VentStar Resus Neo hoses are used in medical settings to provide ventilation support. The FDA's classification of this recall as Class I underscores the severity of the issue, as it is the most serious category of recall. Although no serious injuries or deaths have been reported, the potential risks associated with cracked hoses necessitate immediate attention.

Why it matters

The FDA's Class I recall indicates a significant risk to patient safety, highlighting the importance of reliable medical equipment in emergency situations. Ventilation failure can have dire consequences, including potential fatalities. Ensuring that healthcare providers are aware of this recall is critical to prevent harm to patients who rely on these devices.

Implications

Patients relying on ventilation support could be at increased risk if healthcare providers do not respond promptly to the recall. The healthcare industry may face scrutiny regarding the reliability of medical equipment and the processes in place for monitoring safety. This recall could lead to increased regulatory oversight and changes in manufacturing practices to enhance patient safety.

What to watch

Healthcare facilities will need to take immediate action to remove the affected hoses from use and replace them with safe alternatives. Monitoring for any reports of incidents related to this issue will be important in assessing the recall's impact. The FDA and Draeger may provide updates on the situation and any further actions required.